{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T16:01:22Z","timestamp":1776960082283,"version":"3.51.4"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"31","license":[{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8,2]]},"abstract":"<jats:p>In this study, we analyzed the clinical efficacy of Zishen Yutai pills (ZSYTP) combined with metformin hydrochloride on infertile women diagnosed with polycystic ovary syndrome (PCOS) undergoing in vitro fertilization and embryo transfer (IVF-ET). Patients were assigned into 3 groups: the ZSYTP group (n\u2005=\u200550), the metformin group (n\u2005=\u200550), and the combination group (ZSYTP combined with metformin hydrochloride, n\u2005=\u200550), based on their respective and the indicated treatments before undergoing IVF-ET. Then, their glucose metabolism indices, sex hormone indices, traditional Chinese medicine (TCM) syndrome scores, and outcomes of IVF-ET were compared. Baseline characteristics were not significantly different between the 2 groups. After treatment, various parameters such as body mass index (BMI), fasting plasma glucose (FPG), fasting insulin (FIN), homeostatic model assessment of insulin resistance (HOMA-IR), luteinizing hormone (LH), estradiol (E2), follicle-stimulating hormone (FSH), testosterone (T) levels, and TCM syndrome scores were found to be reduced compared to pretreatment levels in both groups. Moreover, the improvement observed in the treatment group exceeded that of the control group. Specifically, the observation group displayed significantly lower gonadotropin (Gn) dosage and duration, as well as a reduced abortion rate compared to the control group. Furthermore, the observation group had higher numbers of obtained eggs, high-quality embryos, eggs obtained through IVF-ET, average transferred embryos, clinical pregnancy rate, and embryo implantation rate compared to the control group. Pretreatment with ZSYTP combined with metformin before IVF-ET in PCOS patients improves the outcome of IVF-ET.<\/jats:p>","DOI":"10.1097\/md.0000000000039030","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T17:37:14Z","timestamp":1722620234000},"page":"e39030","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Effects of Zishen Yutai pills combined with metformin on women with polycystic ovary syndrome undergoing in vitro fertilization"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7426-7371","authenticated-orcid":false,"given":"Yu","family":"Zhang","sequence":"first","affiliation":[{"name":"Reproductive Department, Hebei Key Laboratory of Reproductive Medicine, Hebei Institute of Reproductive Health Science and Technology, Shijiazhuang, Hebei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Cao","sequence":"additional","affiliation":[{"name":"Reproductive Department, Hebei Key Laboratory of Reproductive Medicine, Hebei Institute of Reproductive Health Science and Technology, Shijiazhuang, Hebei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-xia","family":"Liang","sequence":"additional","affiliation":[{"name":"Reproductive Department, Hebei Key Laboratory of Reproductive Medicine, Hebei Institute of Reproductive Health Science and Technology, Shijiazhuang, Hebei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-hong","family":"Hu","sequence":"additional","affiliation":[{"name":"Reproductive Department, Hebei Key Laboratory of Reproductive Medicine, Hebei Institute of Reproductive Health Science and Technology, Shijiazhuang, Hebei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu-fang","family":"Guo","sequence":"additional","affiliation":[{"name":"Reproductive Department, Hebei Key Laboratory of Reproductive Medicine, Hebei Institute of Reproductive Health Science and Technology, Shijiazhuang, Hebei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi","family":"Chun-jing","sequence":"additional","affiliation":[{"name":"Reproductive Department, Hebei Key Laboratory of Reproductive Medicine, Hebei Institute of Reproductive Health Science and Technology, Shijiazhuang, Hebei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-na","family":"Ge","sequence":"additional","affiliation":[{"name":"Reproductive Department, Hebei Key Laboratory of Reproductive Medicine, Hebei Institute of Reproductive Health Science and Technology, Shijiazhuang, Hebei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3390\/ijms23020583","article-title":"Polycystic ovary syndrome: a comprehensive review of pathogenesis, management, and drug repurposing.","volume":"23","author":"Sadeghi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"e1071","DOI":"10.1210\/clinem\/dgaa839","article-title":"Update on PCOS: consequences, challenges, and guiding treatment.","volume":"106","author":"Hoeger","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"387","DOI":"10.21037\/atm-20-1592","article-title":"Progesterone protocol versus gonadotropin-releasing hormone antagonist protocol in women with polycystic ovarian syndrome undergoing in vitro fertilization treatments with frozen-thawed embryo transfer: a prospective randomized controlled trial.","volume":"9","author":"Zhu","year":"2021","journal-title":"Ann Transl Med"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"114523","DOI":"10.1016\/j.jep.2021.114523","article-title":"Therapeutic importance of Zishen Yutai Pill on the female reproductive health: a review.","volume":"281","author":"Maharajan","year":"2021","journal-title":"J Ethnopharmacol"},{"key":"R5-20250503","first-page":"369","article-title":"Clinical observation on effect of Zishen Yutai Pills on endometrial receptivity in IVF-ET patients with repeated failure of kidney deficiency.","volume":"38","author":"Li","year":"2019","journal-title":"J Tianjin Univ Tradit Chin Med"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11655-023-3546-y","article-title":"Effects of Zishen Yutai Pills on in vitro fertilization-embryo transfer outcomes in patients with diminished ovarian reserve: a prospective, open-labeled, randomized and controlled study.","volume":"29","author":"Li","year":"2023","journal-title":"Chin J Integr Med"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1757-2215-4-8","article-title":"Metformin therapy in a hyperandrogenic anovulatory mutant murine model with polycystic ovarian syndrome characteristics improves oocyte maturity during superovulation.","volume":"4","author":"Sabatini","year":"2011","journal-title":"J Ovarian Res"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"101517","DOI":"10.1016\/j.redox.2020.101517","article-title":"Mechanisms of action of metformin in type 2 diabetes: effects on mitochondria and leukocyte-endothelium interactions.","volume":"34","author":"Apostolova","year":"2020","journal-title":"Redox Biol"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"R10-20250503","first-page":"56","article-title":"Treatment of polycystic ovary syndrome infertility with kidney yang deficiency by Zishen Yutai pills.","volume":"52","author":"Xu","year":"2021","journal-title":"Fujian J Tradit Chin Med"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"E480","DOI":"10.1210\/jc.2010-1658","article-title":"Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS.","volume":"96","author":"Kandaraki","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/0974-1208.130802","article-title":"Obstetric complications in women with IVF conceived pregnancies and polycystic ovarian syndrome.","volume":"7","author":"Tandulwadkar","year":"2014","journal-title":"J Hum Reprod Sci"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.fertnstert.2011.07.1094","article-title":"Ureteral injury after transvaginal ultrasound-guided oocyte retrieval: a complication of in vitro fertilization-embryo transfer that may lurk undetected in women presenting with severe ovarian hyperstimulation syndrome.","volume":"96","author":"Grynberg","year":"2011","journal-title":"Fertil Steril"},{"key":"R15-20250503","first-page":"76","article-title":"Impact of various parameters as predictors of the success rate of in vitro fertilization.","volume":"16","author":"Dabbagh Rezaeiyeh","year":"2022","journal-title":"Int J Fertil Steril"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"e0242024","DOI":"10.1371\/journal.pone.0242024","article-title":"The effect of psychological distress on IVF outcomes: reality or speculations?","volume":"15","author":"Aimagambetova","year":"2020","journal-title":"PLoS One"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.3736\/jcim20111204","article-title":"Exploring the effects of Chinese medicine in improving uterine endometrial blood flow for increasing the successful rate of in vitro fertilization and embryo transfer.","volume":"9","author":"Guo","year":"2011","journal-title":"Zhong Xi Yi Jie He Xue Bao"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3390\/healthcare9030257","article-title":"Understanding traditional Chinese medicine therapeutics: an overview of the basics and clinical applications.","volume":"9","author":"Matos","year":"2021","journal-title":"Healthcare (Basel)"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"686133","DOI":"10.3389\/fphar.2021.686133","article-title":"Metabonomics study on the infertility treated with Zishen Yutai Pills combined with in vitro fertilization-embryo transfer.","volume":"12","author":"Li","year":"2021","journal-title":"Front Pharmacol"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"113570","DOI":"10.1016\/j.jpba.2020.113570","article-title":"Development of a comprehensive method combining UHPLC-CAD fingerprint, multi-components quantitative analysis for quality evaluation of Zishen Yutai Pills: a step towards quality control of Chinese patent medicine.","volume":"191","author":"Cao","year":"2020","journal-title":"J Pharm Biomed Anal"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"113045","DOI":"10.1016\/j.jep.2020.113045","article-title":"Multiple fingerprint profiling for quality evaluation of polysaccharides and related biological activity analysis of Chinese patent drugs: Zishen Yutai Pills as a case study.","volume":"260","author":"Li","year":"2020","journal-title":"J Ethnopharmacol"},{"key":"R22-20250503","first-page":"379","article-title":"Efficacy and mechanism of electroacupuncture on insulin resistant polycystic ovary syndrome.","volume":"40","author":"Yu","year":"2020","journal-title":"Zhongguo Zhen Jiu"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1007\/s10815-022-02577-y","article-title":"The effect of metformin treatment on leukocyte telomere length in patients with polycystic ovary syndrome: a prospective case-control study.","volume":"39","author":"Kayacik Gunday","year":"2022","journal-title":"J Assist Reprod Genet"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1210\/en.2012-1145","article-title":"Metformin inhibits human androgen production by regulating steroidogenic enzymes HSD3B2 and CYP17A1 and complex I activity of the respiratory chain.","volume":"153","author":"Hirsch","year":"2012","journal-title":"Endocrinology"},{"key":"R25-20250503","first-page":"195","article-title":"Effect and mechanism of metformin on ovulation in patients with polycystic ovary syndrome.","volume":"20","author":"Tang","year":"2016","journal-title":"J Clin Med Pract"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/humupd\/dmv025","article-title":"Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.","volume":"21","author":"Naderpoor","year":"2015","journal-title":"Hum Reprod Update"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejogrb.2011.07.005","article-title":"Clinical, endocrine and metabolic effects of metformin vs N-acetyl-cysteine in women with polycystic ovary syndrome.","volume":"159","author":"Oner","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R28-20250503","doi-asserted-by":"crossref","first-page":"980S","DOI":"10.3945\/ajcn.2008.26788C","article-title":"Leptin: a pivotal regulator of human energy homeostasis.","volume":"89","author":"Farooqi","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s13679-019-00335-3","article-title":"Metformin: mechanisms in human obesity and weight loss.","volume":"8","author":"Yerevanian","year":"2019","journal-title":"Curr Obes Rep"},{"key":"R30-20250503","first-page":"3","article-title":"Effect of Zishenyutai Pills combined with triptorelin on pregnancy outcome in patients undergoing in vitro fertilization embryo transfer.","volume":"30","author":"Cao","year":"2021","journal-title":"China Pharm"},{"key":"R31-20250503","first-page":"27","article-title":"Diagnosis and management of polycystic ovary syndrome.","volume":"2015","author":"Kochhar","year":"2015","journal-title":"Indep Nurse"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/humrep\/del025","article-title":"The use of metformin for women with PCOS undergoing IVF treatment.","volume":"21","author":"Tang","year":"2006","journal-title":"Hum Reprod"},{"key":"R33-20250503","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.fertnstert.2011.09.020","article-title":"Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial.","volume":"96","author":"Palomba","year":"2011","journal-title":"Fertil Steril"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000039030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:12:30Z","timestamp":1746317550000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000039030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,2]]},"references-count":32,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000039030","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,2]]}}}